PICTON MAHONEY ASSET MANAGEMENT - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
PICTON MAHONEY ASSET MANAGEMENT ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$161,000
-56.6%
6,400
-57.3%
0.01%
-48.0%
Q3 2016$371,000
+23.3%
15,000
+1.4%
0.02%
+31.6%
Q2 2016$301,000
-55.7%
14,800
-70.7%
0.02%
-53.7%
Q4 2015$679,000
-35.7%
50,500
-32.9%
0.04%
-32.8%
Q3 2015$1,056,00075,3000.06%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders